File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/embr.201338181
- Scopus: eid_2-s2.0-84901783915
- PMID: 24711543
- WOS: WOS:000337360300015
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: BIG3 inhibits insulin granule biogenesis and insulin secretion.
Title | BIG3 inhibits insulin granule biogenesis and insulin secretion. |
---|---|
Authors | |
Keywords | insulin granule biogenesis insulin resistance insulin secretion metabolism proinsulin processing |
Issue Date | 2014 |
Publisher | Nature Publishing Group. The Journal's web site is located at http://www.emboreports.org |
Citation | EMBO Reports, 2014, v. 15 n. 6, p. 714-722 How to Cite? |
Abstract | While molecular regulation of insulin granule exocytosis is relatively well understood, insulin granule biogenesis and maturation and its influence on glucose homeostasis are relatively unclear. Here, we identify a novel protein highly expressed in insulin-secreting cells and name it BIG3 due to its similarity to BIG/GBF of the Arf-GTP exchange factor (GEF) family. BIG3 is predominantly localized to insulin- and clathrin-positive trans-Golgi network (TGN) compartments. BIG3-deficient insulin-secreting cells display increased insulin content and granule number and elevated insulin secretion upon stimulation. Moreover, BIG3 deficiency results in faster processing of proinsulin to insulin and chromogranin A to β-granin in β-cells. BIG3-knockout mice exhibit postprandial hyperinsulinemia, hyperglycemia, impaired glucose tolerance, and insulin resistance. Collectively, these results demonstrate that BIG3 negatively modulates insulin granule biogenesis and insulin secretion and participates in the regulation of systemic glucose homeostasis. © 2014 Singapore Bioimaging Consortium, A*STAR. |
Persistent Identifier | http://hdl.handle.net/10722/196793 |
ISSN | 2023 Impact Factor: 6.5 2023 SCImago Journal Rankings: 3.193 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, H | - |
dc.contributor.author | Wei, S | - |
dc.contributor.author | Cheng, KY | - |
dc.contributor.author | Gounko, NV | - |
dc.contributor.author | Ericksen, RE | - |
dc.contributor.author | Xu, A | - |
dc.contributor.author | Hong, W | - |
dc.contributor.author | Han, W | - |
dc.date.accessioned | 2014-04-29T03:41:33Z | - |
dc.date.available | 2014-04-29T03:41:33Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | EMBO Reports, 2014, v. 15 n. 6, p. 714-722 | - |
dc.identifier.issn | 1469-221X | - |
dc.identifier.uri | http://hdl.handle.net/10722/196793 | - |
dc.description.abstract | While molecular regulation of insulin granule exocytosis is relatively well understood, insulin granule biogenesis and maturation and its influence on glucose homeostasis are relatively unclear. Here, we identify a novel protein highly expressed in insulin-secreting cells and name it BIG3 due to its similarity to BIG/GBF of the Arf-GTP exchange factor (GEF) family. BIG3 is predominantly localized to insulin- and clathrin-positive trans-Golgi network (TGN) compartments. BIG3-deficient insulin-secreting cells display increased insulin content and granule number and elevated insulin secretion upon stimulation. Moreover, BIG3 deficiency results in faster processing of proinsulin to insulin and chromogranin A to β-granin in β-cells. BIG3-knockout mice exhibit postprandial hyperinsulinemia, hyperglycemia, impaired glucose tolerance, and insulin resistance. Collectively, these results demonstrate that BIG3 negatively modulates insulin granule biogenesis and insulin secretion and participates in the regulation of systemic glucose homeostasis. © 2014 Singapore Bioimaging Consortium, A*STAR. | - |
dc.language | eng | - |
dc.publisher | Nature Publishing Group. The Journal's web site is located at http://www.emboreports.org | - |
dc.relation.ispartof | EMBO Reports | - |
dc.subject | insulin granule biogenesis | - |
dc.subject | insulin resistance | - |
dc.subject | insulin secretion | - |
dc.subject | metabolism | - |
dc.subject | proinsulin processing | - |
dc.title | BIG3 inhibits insulin granule biogenesis and insulin secretion. | - |
dc.type | Article | - |
dc.identifier.email | Cheng, KY: dorncky@hkucc.hku.hk | - |
dc.identifier.email | Xu, A: amxu@hkucc.hku.hk | - |
dc.identifier.authority | Cheng, KY=rp01672 | - |
dc.identifier.authority | Xu, A=rp00485 | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1002/embr.201338181 | - |
dc.identifier.pmid | 24711543 | - |
dc.identifier.pmcid | PMC4197882 | - |
dc.identifier.scopus | eid_2-s2.0-84901783915 | - |
dc.identifier.hkuros | 228676 | - |
dc.identifier.volume | 15 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 714 | - |
dc.identifier.epage | 722 | - |
dc.identifier.isi | WOS:000337360300015 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 1469-221X | - |